Skip to main content

Unable to load price data. Sorry.

¯\_(ツ)_/¯

Orchid Cellmark, Inc. (NASDAQ:ORCH.DL)

CAPS Rating: No stars

The Company is engaged in the provision of DNA testing services that generate genetic profile information by analyzing an organism's unique genetic identity.

Unable to load market data for this Ticker. Sorry.

¯\_(ツ)_/¯

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

0 Outperform
0 Underperform
 

All-Star Players

0 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:ORCH.DL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

KansasGold (88.24)
Submitted May 04, 2007

beat earnings and is beat down. i love this combination

gotoschool (< 20)
Submitted May 29, 2007

I've had high hopes for my Orchid stock for the last 6+ years. They have always let me down. A 1 for 7 reverse split! The board now wants me to approve the issuance of additional stock. The business sounds like a good area to invest in, but they have… More

NASDAQ:ORCH.DL VS S&P 500 (SPY)

NASDAQ:ORCH.DL Summary

  • Sector:
  • Industry:
  • Tags:

Recent Community Commentary

Read the most recent pitches from players about ORCH.DL.

No one has written a Pitch for ORCH.DL stock yet. Tell us why you think ORCH.DL will outperform or underperform against the market.

Leaderboard

Find the members with the highest scoring picks in ORCH.DL.

No players have picked ORCH.DL yet. Tell us why you think ORCH.DL will outperform or underperform against the market.

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for ORCH.DL.